Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 2,205 | 1,770 | 1,540 | 2,082 | 1,559 |
| Cost of Goods | 863 | 692 | 661 | 932 | 952 |
| Gross Profit | 1,343 | 1,078 | 879 | 1,150 | 608 |
| Operating Expenses | 2,006 | 1,729 | 1,998 | 2,069 | 1,769 |
| Operating Income | 199 | 41 | -459 | 13 | -210 |
| Other Income | -11 | -11 | -16 | -11 | -43 |
| Pre-tax Income | 188 | 30 | -475 | 1 | -253 |
| Income Tax | 58 | 19 | -180 | 15 | -102 |
| Net Income Continuous | 131 | 10 | -295 | -13 | -151 |
| Net Income | $131 | $10 | $-295 | $-13 | $-151 |
| EPS Basic Total Ops | 0.04 | 0.00 | -0.10 | 0.00 | -0.05 |
| EPS Basic Continuous Ops | 0.04 | 0.00 | -0.10 | 0.00 | -0.05 |
| EPS Diluted Total Ops | 0.04 | 0.00 | -0.10 | 0.00 | -0.05 |
| EPS Diluted Continuous Ops | 0.04 | 0.00 | -0.10 | 0.00 | -0.05 |
| EBITDA(a) | $315 | $145 | $-343 | $126 | $-88 |